169 related articles for article (PubMed ID: 20483917)
1. Runx1 binds as a dimeric complex to overlapping Runx1 sites within a palindromic element in the human GM-CSF enhancer.
Bowers SR; Calero-Nieto FJ; Valeaux S; Fernandez-Fuentes N; Cockerill PN
Nucleic Acids Res; 2010 Oct; 38(18):6124-34. PubMed ID: 20483917
[TBL] [Abstract][Full Text] [Related]
2. Granulocyte-macrophage colony-stimulating factor enhancer activation requires cooperation between NFAT and AP-1 elements and is associated with extensive nucleosome reorganization.
Johnson BV; Bert AG; Ryan GR; Condina A; Cockerill PN
Mol Cell Biol; 2004 Sep; 24(18):7914-30. PubMed ID: 15340054
[TBL] [Abstract][Full Text] [Related]
3. Regulation of GM-CSF gene transcription by core-binding factor.
Cockerill PN; Osborne CS; Bert AG; Grotto RJ
Cell Growth Differ; 1996 Jul; 7(7):917-22. PubMed ID: 8809409
[TBL] [Abstract][Full Text] [Related]
4. Human granulocyte-macrophage colony-stimulating factor enhancer function is associated with cooperative interactions between AP-1 and NFATp/c.
Cockerill PN; Bert AG; Jenkins F; Ryan GR; Shannon MF; Vadas MA
Mol Cell Biol; 1995 Apr; 15(4):2071-9. PubMed ID: 7891702
[TBL] [Abstract][Full Text] [Related]
5. AML1/Runx1 recruits calcineurin to regulate granulocyte macrophage colony-stimulating factor by Ets1 activation.
Liu H; Holm M; Xie XQ; Wolf-Watz M; Grundström T
J Biol Chem; 2004 Jul; 279(28):29398-408. PubMed ID: 15123671
[TBL] [Abstract][Full Text] [Related]
6. The core binding factor CBF negatively regulates skeletal muscle terminal differentiation.
Philipot O; Joliot V; Ait-Mohamed O; Pellentz C; Robin P; Fritsch L; Ait-Si-Ali S
PLoS One; 2010 Feb; 5(2):e9425. PubMed ID: 20195544
[TBL] [Abstract][Full Text] [Related]
7. Identification of benzodiazepine Ro5-3335 as an inhibitor of CBF leukemia through quantitative high throughput screen against RUNX1-CBFβ interaction.
Cunningham L; Finckbeiner S; Hyde RK; Southall N; Marugan J; Yedavalli VR; Dehdashti SJ; Reinhold WC; Alemu L; Zhao L; Yeh JR; Sood R; Pommier Y; Austin CP; Jeang KT; Zheng W; Liu P
Proc Natl Acad Sci U S A; 2012 Sep; 109(36):14592-7. PubMed ID: 22912405
[TBL] [Abstract][Full Text] [Related]
8. Allosteric inhibition of the protein-protein interaction between the leukemia-associated proteins Runx1 and CBFbeta.
Gorczynski MJ; Grembecka J; Zhou Y; Kong Y; Roudaia L; Douvas MG; Newman M; Bielnicka I; Baber G; Corpora T; Shi J; Sridharan M; Lilien R; Donald BR; Speck NA; Brown ML; Bushweller JH
Chem Biol; 2007 Oct; 14(10):1186-97. PubMed ID: 17961830
[TBL] [Abstract][Full Text] [Related]
9. Characterization of RNA aptamers that disrupt the RUNX1-CBFbeta/DNA complex.
Barton JL; Bunka DH; Knowling SE; Lefevre P; Warren AJ; Bonifer C; Stockley PG
Nucleic Acids Res; 2009 Nov; 37(20):6818-30. PubMed ID: 19740763
[TBL] [Abstract][Full Text] [Related]
10. PEBP2-beta/CBF-beta-dependent phosphorylation of RUNX1 and p300 by HIPK2: implications for leukemogenesis.
Wee HJ; Voon DC; Bae SC; Ito Y
Blood; 2008 Nov; 112(9):3777-87. PubMed ID: 18695000
[TBL] [Abstract][Full Text] [Related]
11. Crlz1 activates transcription by mobilizing cytoplasmic CBFbeta into the nucleus.
Park SK; Lim JH; Kang CJ
Biochim Biophys Acta; 2009; 1789(11-12):702-8. PubMed ID: 19735751
[TBL] [Abstract][Full Text] [Related]
12. A novel allosteric mechanism on protein-DNA interactions underlying the phosphorylation-dependent regulation of Ets1 target gene expressions.
Shiina M; Hamada K; Inoue-Bungo T; Shimamura M; Uchiyama A; Baba S; Sato K; Yamamoto M; Ogata K
J Mol Biol; 2015 Apr; 427(8):1655-69. PubMed ID: 25083921
[TBL] [Abstract][Full Text] [Related]
13. Core binding factor in the early avian embryo: cloning of Cbfbeta and combinatorial expression patterns with Runx1.
Bollerot K; Romero S; Dunon D; Jaffredo T
Gene Expr Patterns; 2005 Dec; 6(1):29-39. PubMed ID: 16033710
[TBL] [Abstract][Full Text] [Related]
14. RUNX1 is required for oncogenic
Choi A; Illendula A; Pulikkan JA; Roderick JE; Tesell J; Yu J; Hermance N; Zhu LJ; Castilla LH; Bushweller JH; Kelliher MA
Blood; 2017 Oct; 130(15):1722-1733. PubMed ID: 28790107
[TBL] [Abstract][Full Text] [Related]
15. Proleukemic RUNX1 and CBFbeta mutations in the pathogenesis of acute leukemia.
Engel ME; Hiebert SW
Cancer Treat Res; 2010; 145():127-47. PubMed ID: 20306249
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional and epigenetic regulation of the GM-CSF promoter by RUNX1.
Oakford PC; James SR; Qadi A; West AC; Ray SN; Bert AG; Cockerill PN; Holloway AF
Leuk Res; 2010 Sep; 34(9):1203-13. PubMed ID: 20439113
[TBL] [Abstract][Full Text] [Related]
17. Subnuclear targeting of Runx1 is required for synergistic activation of the myeloid specific M-CSF receptor promoter by PU.1.
Li X; Vradii D; Gutierrez S; Lian JB; van Wijnen AJ; Stein JL; Stein GS; Javed A
J Cell Biochem; 2005 Nov; 96(4):795-809. PubMed ID: 16149049
[TBL] [Abstract][Full Text] [Related]
18. The +37 kb Cebpa Enhancer Is Critical for Cebpa Myeloid Gene Expression and Contains Functional Sites that Bind SCL, GATA2, C/EBPα, PU.1, and Additional Ets Factors.
Cooper S; Guo H; Friedman AD
PLoS One; 2015; 10(5):e0126385. PubMed ID: 25938608
[TBL] [Abstract][Full Text] [Related]
19. Molecular mechanisms of cooperative binding of transcription factors Runx1-CBFβ-Ets1 on the TCRα gene enhancer.
Kasahara K; Shiina M; Fukuda I; Ogata K; Nakamura H
PLoS One; 2017; 12(2):e0172654. PubMed ID: 28231333
[TBL] [Abstract][Full Text] [Related]
20. Crystallization of the Ets1-Runx1-CBFβ-DNA complex formed on the TCRα gene enhancer.
Shiina M; Hamada K; Inoue-Bungo T; Shimamura M; Baba S; Sato K; Ogata K
Acta Crystallogr F Struct Biol Commun; 2014 Oct; 70(Pt 10):1380-4. PubMed ID: 25286944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
